Arkema OTC Stock Quote Today


USD 91.30  0.00  0.00%   

Market Performance
0 of 100
Odds Of Distress
Less than 36
Arkema is trading at 91.30 as of the 11th of August 2022, a No Change since the beginning of the trading day. The stock's lowest day price was 91.3. Arkema has about a 36 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Arkema are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 13th of May 2022 and ending today, the 11th of August 2022. Click here to learn more.
Fiscal Year End
Basic Materials
Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France. Arkema operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. The company has 73.97 M outstanding shares. More on Arkema

Moving against Arkema

0.81CBAYCymabay Therapeutics Earnings Call  TodayPairCorr
0.73ALTAltimmune Earnings Call  TodayPairCorr
0.72QCOMQualcomm Tech BoostPairCorr
0.69HYLNHyliion Hldg Corp Aggressive PushPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Arkema OTC Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Arkema's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Arkema or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Arkema generated a negative expected return over the last 90 days
Arkema has high historical volatility and very poor performance
Latest headline from Full Swing Rollout of 5G Networks to Propel Use of Low-Loss Materials in Near Future, States Fact.MR - Yahoo Finance
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Arkema's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Arkema's managers, analysts, and investors.
Environment Score
Governance Score
Social Score
ChairmanThierry Henaff
Excise Tax ActivitiesAnimal Testing
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Arkema's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Cautious HoldOvervalued
Arkema [ARKAF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Mid-Cap' category with current market capitalization of 6.94 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Arkema's market, we take the total number of its shares issued and multiply it by Arkema's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Arkema classifies itself under Basic Materials sector and is part of Specialty Chemicals industry. The entity has 73.97 M outstanding shares. Arkema has accumulated about 1.34 B in cash with 1.01 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 18.14.
Check Arkema Probability Of Bankruptcy
Arkema retains a total of 73.97 Million outstanding shares. Over half of Arkema outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulation than regular investors in Arkema. Please watch out for any change in the institutional holdings of Arkema as this could mean something significant has changed or about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.

Ownership Allocation (%)

Check Arkema Ownership Details

Arkema Stock Price Odds Analysis

What are Arkema's target price odds to finish over the current price? Based on a normal probability distribution, the odds of Arkema jumping above the current price in 90 days from now is about 90.67%. The Arkema probability density function shows the probability of Arkema otc stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Arkema has a beta of 0.0839. This suggests as returns on the market go up, Arkema average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Arkema will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Arkema is significantly underperforming DOW.
  Odds Below 91.3HorizonTargetOdds Above 91.3
9.28%90 days
Based on a normal probability distribution, the odds of Arkema to move above the current price in 90 days from now is about 90.67 (This Arkema probability density function shows the probability of Arkema OTC Stock to fall within a particular range of prices over 90 days) .

Arkema Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Arkema market risk premium is the additional return an investor will receive from holding Arkema long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Arkema. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Arkema's alpha and beta are two of the key measurements used to evaluate Arkema's performance over the market, the standard measures of volatility play an important role as well.

Arkema Stock Against Markets

Picking the right benchmark for Arkema otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Arkema otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Arkema is critical whether you are bullish or bearish towards Arkema at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Arkema without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Transaction History Now


Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Module

Arkema Corporate Directors

Arkema corporate directors refer to members of an Arkema board of directors. The board of directors generally takes responsibility for the Arkema's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Arkema's board members must vote for the resolution. The Arkema board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Patrice Breant - Director - Shareholder Employees RepresentativeProfile
JeanMarc Bertrand - Non-Executive Director Representing Shareholder EmployeesProfile
Victoire Margerie - Independent DirectorProfile
Helene MoreauLeroy - Non-Executive Independent DirectorProfile

Invested in Arkema?

You need to understand the risk of investing before taking a position in Arkema. The danger of trading Arkema is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Arkema is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Arkema. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Arkema is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. Note that the Arkema information on this page should be used as a complementary analysis to other Arkema's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Complementary Tools for Arkema OTC Stock analysis

When running Arkema price analysis, check to measure Arkema's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arkema is operating at the current time. Most of Arkema's value examination focuses on studying past and present price action to predict the probability of Arkema's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arkema's price. Additionally, you may evaluate how the addition of Arkema to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Is Arkema's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arkema. If investors know Arkema will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arkema listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Arkema is measured differently than its book value, which is the value of Arkema that is recorded on the company's balance sheet. Investors also form their own opinion of Arkema's value that differs from its market value or its book value, called intrinsic value, which is Arkema's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arkema's market value can be influenced by many factors that don't directly affect Arkema's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arkema's value and its price as these two are different measures arrived at by different means. Investors typically determine Arkema value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arkema's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.